Clinical trial NCT03049917: Financial Incentives to Increase Pediatric HIV Testing
Official title: Financial Incentives to Increase Pediatric HIV Testing
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: HIV
Keywords: financial incentive
pediatric HIV testing
Lead sponsor: University of Washington
Sponsor class: OTHER
Collaborators: name: Kenyatta National Hospital
name: University of Nairobi
First posted: 2017-02-10
Enrollment: 452
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: DIAGNOSTIC

Brief summary: The purpose of this study is to determine whether giving small financial incentives will motivate parents to test their children for HIV.

Detailed description: The study will be a randomized controlled trial (RCT) with 5 arms with equal allocation to each arm: no incentive, or one of 4 different levels of financial incentive. We will randomize 800 parents with children of unknown status at HIV treatment clinics in Western Kenya.

Eligibility criteria: Inclusion Criteria:

* Parent/caregiver receiving HIV care
* Parent/caregiver has one or more children \<13 years old
* Child is HIV exposed (parent/caregiver report or clinic confirmation)
* Caregiver reports child's HIV status is unknown

Exclusion Criteria:

* None

  * The investigators reserve the right to exclude any potential enrollee who is deemed to be at high personal risk, or whose children are at high personal risk, of interpersonal violence, by study participation .

Primary outcomes:
measure: Number of Participants Who Present Children for HIV Testing
timeFrame: 2 months
measure: Number of Days Participants Take to Bring Children for HIV Testing
timeFrame: 2 months
Secondary outcomes:
measure: Number of Female Participants Who Present Children for HIV Testing (Females)
timeFrame: 2 months
measure: Number of Male Participants Who Present Children for HIV Testing
timeFrame: 2 months
measure: Number of Caregivers With One Child Who Present Children for HIV Testing
timeFrame: 2 months
measure: Number of Participants With More Than 1 Child Who Present Children for HIV Testing
timeFrame: 2 months
measure: Number of Caregivers With Age Less Than Median Presenting Children for HIV Testing
timeFrame: 2 months
measure: Number of Caregivers With Age More Than Median Presenting Children for HIV Testing
timeFrame: 2 months
Other outcomes:
Locations:
city: Kisumu
country: Kenya
facility: Kisumu County Hospital
Study officials:
affiliation: University of Washington
name: Jennifer A Slyker, PhD
role: PRINCIPAL_INVESTIGATOR
affiliation: University of Washington/Kenyatta National Hospital
name: Irene N Njugna, MBChB, Msc
role: PRINCIPAL_INVESTIGATOR
References:
citation: Wagner AD, Njuguna IN, Neary J, Omondi VO, Otieno VA, Babigumira J, Maleche-Obimbo E, Wamalwa DC, John-Stewart GC, Slyker JA. Financial Incentives to Increase Uptake of Pediatric HIV Testing (FIT): study protocol for a randomised controlled trial in Kenya. BMJ Open. 2018 Oct 3;8(10):e024310. doi: 10.1136/bmjopen-2018-024310.
citation: Njuguna IN, Wagner AD, Omondi VO, Otieno VA, Neary J, Bosire R, Babigumira JB, Levin C, Maleche-Obimbo E, Wamalwa DC, John-Stewart G, Slyker J. Financial Incentives for Pediatric HIV Testing in Kenya. Pediatr Infect Dis J. 2018 Nov;37(11):1142-1144. doi: 10.1097/INF.0000000000002035.
citation: Atkins DL, Wagner AD, Zhang J, Njuguna IN, Neary J, Omondi VO, Otieno VA, Ondeng'e K, Wamalwa DC, John-Stewart G, Slyker JA, Beima-Sofie K. Brief Report: Use of the Consolidated Framework for Implementation Research (CFIR) to Characterize Health Care Workers' Perspectives on Financial Incentives to Increase Pediatric HIV Testing. J Acquir Immune Defic Syndr. 2020 May 1;84(1):e1-e6. doi: 10.1097/QAI.0000000000002323.
citation: Njuguna IN, Wagner AD, Neary J, Omondi VO, Otieno VA, Orimba A, Mugo C, Babigumira JB, Levin C, Richardson BA, Maleche-Obimbo E, Wamalwa DC, John-Stewart G, Slyker J. Financial incentives to increase pediatric HIV testing: a randomized trial. AIDS. 2021 Jan 1;35(1):125-130. doi: 10.1097/QAD.0000000000002720.